Beta thalassemia
ICD-10 D56.1 is a billable code used to indicate a diagnosis of beta thalassemia.
Beta thalassemia is a genetic blood disorder characterized by reduced production of hemoglobin due to mutations in the HBB gene on chromosome 11. This condition leads to ineffective erythropoiesis and hemolytic anemia, resulting in symptoms such as fatigue, pallor, and splenomegaly. Patients may experience varying degrees of severity, with beta thalassemia minor typically presenting with mild anemia and beta thalassemia major (Cooley's anemia) leading to severe anemia requiring regular blood transfusions. The condition is prevalent in populations from the Mediterranean region, the Middle East, and Southeast Asia. Diagnosis is confirmed through hemoglobin electrophoresis, which reveals abnormal hemoglobin patterns. Management includes regular monitoring, blood transfusions, iron chelation therapy to prevent iron overload, and in some cases, hematopoietic stem cell transplantation. Genetic counseling is recommended for affected families to understand inheritance patterns and reproductive options.
Detailed lab results, genetic testing, and treatment plans.
Management of patients with beta thalassemia major requiring transfusions.
Ensure documentation reflects the severity and type of thalassemia for accurate coding.
Family history, genetic test results, and counseling notes.
Genetic counseling for families with a history of thalassemia.
Document inheritance patterns and potential risks for offspring.
Used to monitor hemoglobin levels in patients with beta thalassemia.
Document the reason for the CBC and any relevant patient history.
Hematology specialists should ensure accurate interpretation of results.
Beta thalassemia minor typically presents with mild anemia and may not require treatment, while beta thalassemia major leads to severe anemia and requires regular blood transfusions and management of complications.
